Résultats de la recherche - Karsten-H. Weylandt

Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma par Can G. Leineweber, Can G. Leineweber, Can G. Leineweber, Miriam Rabehl, Miriam Rabehl, Anne Pietzner, Anne Pietzner, Nadine Rohwer, Nadine Rohwer, Nadine Rohwer, Michael Rothe, Maciej Pech, Bruno Sangro, Rohini Sharma, Chris Verslype, Bristi Basu, Christian Sengel, Jens Ricke, Nils Helge Schebb, Karsten-H. Weylandt, Karsten-H. Weylandt, Julia Benckert

Connect to this object online.

Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma par Can G. Leineweber, Can G. Leineweber, Can G. Leineweber, Miriam Rabehl, Miriam Rabehl, Anne Pietzner, Anne Pietzner, Nadine Rohwer, Nadine Rohwer, Nadine Rohwer, Michael Rothe, Maciej Pech, Bruno Sangro, Rohini Sharma, Chris Verslype, Bristi Basu, Christian Sengel, Jens Ricke, Nils Helge Schebb, Karsten-H. Weylandt, Karsten-H. Weylandt, Julia Benckert

Connect to this object online.

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far? par Nils Helge Schebb, Hartmut Kühn, Astrid S. Kahnt, Katharina M. Rund, Valerie B. O'Donnell, Nicolas Flamand, Marc Peters-Golden, Per-Johan Jakobsson, Karsten H. Weylandt, Nadine Rohwer, Nadine Rohwer, Robert C. Murphy, Gerd Geisslinger, Gerd Geisslinger, Garret A. FitzGerald, Julien Hanson, Julien Hanson, Claes Dahlgren, Mohamad Wessam Alnouri, Stefan Offermanns, Stefan Offermanns, Dieter Steinhilber, Dieter Steinhilber

Connect to this object online.